Chemistry Today asks Daniel O’Keeffe of Qinecsa Solutions if patient outcomes are getting lost in safety data complexity in a recent article. Daniel explores where AI technology is likely to have most impact in life sciences, and the role regulatory authorities could play to drive improvements. As well as giving a critical analysis of the potential to address the challenge of safety data complexity in life sciences, linking to the diverse information captured about adverse events in patients
